Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 17, 2019

SELL
$35.45 - $48.2 $3,545 - $4,820
-100 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$28.02 - $40.87 $2,802 - $4,086
100 New
100 $4,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $2.95B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Interactive Financial Advisors Portfolio

Follow Interactive Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interactive Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Interactive Financial Advisors with notifications on news.